APOE and Alzheimer disease: Using classification and regression trees (CART) modeling, we showed that these 229 CSF proteins were able to reliably (performance metrics > 0.95) predict APOE ε4 carriers from noncarriers across AD and PD (Extended Data Table 1 and Fig. 1f).